相关实验视频

Updated: Jun 27, 2026

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

该SCANVIR®项目:在新阿奎廷的C型肝炎微消除中取得了成功

Sandrine Francois¹, Gwennaick Villain², Samy Yahiaoui³

¹Hepato-Gastroenterology Department, University Hospital Center, 87042 Limoges, France.

|February 27, 2026

概括

在SCANVIR项目中,在传统医疗保健之外,成功地查和治疗了型肝炎病毒 (HCV) 的高风险人群. 这一举措证明了诊断和治疗HCV的成本效益高的方法,改善了患者的治疗结果.

科学领域:

肝病学肝病学是一种肝病学.
公共卫生公共卫生
传染性疾病传染性疾病

背景情况:

消除C型肝炎病毒 (HCV) 需要接触高风险人群.
传统的医疗保健机构往往无法参与注射毒品的个人,移民和囚犯.

研究的目的:

评估SCANVIR项目的有效性,在难以到达的人群中查和治疗HCV.
评估这些群体中HCV,肝纤维化和脂肪脂肪症的患病率.

主要方法:

在43个机构为静脉注射药物使用者,移民和囚犯组织了查和治疗日.
使用快速测试 (HCV,HBV,HIV),FibroScan进行肝脏评估,以及GeneXpert进行现场HCVRNA检测.
提供预防,成和心理社会支持方面的咨询.

主要成果:

查了1664名患者;23.4%的抗HCV抗体检测呈阳性,其中41.5%具有复制性概况.
17%的患者表现为晚期纤维化,7.2%的患者表现为严重纤维化,18%的患者表现为严重肥胖症.
83%的人开始接受治疗,80%的人治愈或接受治疗.

结论:

该SCANVIR项目有效地诊断和治疗远离护理的人群中的HCV.
将教育和预防纳入查是肝病管理的关键.
"检测,治疗,预防"的策略证明了成本效益.

关键词:

在 GCS NOVA 中,GCS NOVA 是吸毒成吸毒成是一种成.型肝炎微清除的方法肝脏纤维化肝脏纤维化在护理中心进行分子测试.危险性是不稳定的

更多相关视频

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus

Published on: October 1, 2015

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

Published on: November 7, 2018

相关概念视频

Hepatitis

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...

Viral Hepatitis I: Introduction

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...